| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.03 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |